Arabic Arabic English English French French German German
dark

Bio-Techne and Narayana Nethralaya Collaborate on the use of Ella for Ophthalmic Disorder Diagnostic Applications

 Bio-Techne Corporation (NASDAQ: TECH) today announced a collaboration with Narayana Nethralaya to develop a diagnostic solution for ophthalmology disorders on its ProteinSimple branded, multiplexing immunoassay instrument, Ella. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Idera Pharmaceuticals Announces Corporate Updates

Next Post

Agilex Biolabs’ Toxicology Tapped for SARS-CoV-2 Vaccine Research

Related Posts
Total
0
Share